Serotonergic mechanisms and extrapyramidal function in man.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D002526:Cerebellar Diseases / Q000378:metabolism; D007562:Creutzfeldt-Jakob Syndrome / Q000378:metabolism; D004314:Down Syndrome / Q000378:metabolism; D005116:Extrapyramidal Tracts / Q000378:metabolism*; D010134:Fenclonine / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007099:Imipramine / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D009135:Muscular Diseases / Q000378:metabolism; D010243:Paralysis / Q000378:metabolism; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000378:metabolism*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011339:Probenecid; D012110:Reserpine; D012701:Serotonin / Q000378:metabolism* / Q000494:pharmacology; D013118:Spinal Cord Diseases / Q000378:metabolism; D013747:Tetrabenazine; D013997:Time Factors
D012701:Serotonin; D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D012110:Reserpine; D006916:5-Hydroxytryptophan; D002230:Carbidopa; D007099:Imipramine; D011339:Probenecid; D010134:Fenclonine; D006719:Homovanillic Acid; D013747:Tetrabenazine